1.
Flach J, Jann J-C, Knaflic A, Riabov V, Streuer A, Altrock E, Xu Q, Schmitt N, Obländer J, Nowak V, Danner J, Mehralivand A, Hofmann F, Palme I, Jawhar A, Wuchter P, Metzgeroth G, Nolte F, Hofmann W-K, Nowak D. Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations. haematol [Internet]. 2020Sep.14 [cited 2022Sep.24];106(11):2906-17. Available from: https://haematologica.org/article/view/haematol.2020.254193